Abstract
Purpose
The purpose of this study is to assess change in worry over time in Hispanic women with thyroid cancer.
Methods
Worry about recurrence, quality of life, family at risk, death, and harm from treatments was assessed in 273 Hispanic women with thyroid cancer diagnosed in 2014–2015. Subjects were recruited from Surveillance, Epidemiology, and End Results (SEER) Los Angeles. Participants were surveyed at two points in time (time 1: 2017–2018 and time 2: 2019). Multivariable logistic regression was used to determine correlates with high worry (somewhat, quite a bit, very much) versus low worry (not at all, a little) at time 2.
Results
For the five worry items, 20.1–39.6% had high worry at both time 1 and time 2. An additional 7.6–13.4% had low worry at time 1 that became high worry at time 2. In multivariable logistic regression controlling for age, recurrence status, education level, and number of complications or side effects symptoms, younger age (20–39) as compared to older (40–79) was associated with high worry about thyroid cancer recurrence (OR 2.16, 95% CI 1.12–4.17). History of recurrent or persistent disease was associated with high worry about harms from treatment (OR 2.94, 95% CI 1.29–6.67). Greater number of complications or side effects of symptoms was associated with more worry across all five items.
Conclusions
Some Hispanic women with thyroid cancer have persistently high worry, with young adult Hispanic women vulnerable to worry about recurrence.
Implications for Cancer Survivors
Hispanic women with thyroid cancer may benefit from targeted psychosocial support during survivorship, with interventions informed by patient and cancer characteristics.
Similar content being viewed by others
Data and/or code availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Miller KD, Goding Sauer A, Ortiz AP, et al. Cancer statistics for Hispanics/Latinos, 2018. CA Cancer J Clin. 2018;68(6):425–45.
Papaleontiou M, Reyes-Gastelum D, Gay BL, et al. Worry in thyroid cancer survivors with a favorable prognosis. Thyroid. 2019;29(8):1080–8.
Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients. J Cancer Surviv. 2014;8(3):394–401.
Morley S, Goldfarb M. Support needs and survivorship concerns of thyroid cancer patients. Thyroid. 2015;25(6):649–56.
McDonnell GA, Pope AW, Schuler TA, Ford JS. The relationship between cancer-related worry and posttraumatic growth in adolescent and young adult cancer survivors. Psychooncology. 2018;27(9):2155–64.
Wang R, Syed IA, Nathan PC, et al. Exploring cancer worry in adolescent and young adult survivors of childhood cancers. J Adolesc Young Adult Oncol. 2015;4(4):192–9.
Smrke A, Leung B, Srikanthan A, et al. Distinct features of psychosocial distress of adolescents and young adults with cancer compared to adults at diagnosis: patient-reported domains of concern. J Adolesc Young Adult Oncol. 2020;9(4):540–5.
Zebrack B, Mathews-Bradshaw B, Siegel S, Alliance LYA. Quality cancer care for adolescents and young adults: a position statement. J Clin Oncol. 2010;28(32):4862–7.
Levin NJ, Zebrack B, Cole SW. Psychosocial issues for adolescent and young adult cancer patients in a global context: a forward-looking approach. Pediatr Blood Cancer. 2019;66(8):e27789.
Hydeman JA, Uwazurike OC, Adeyemi EI, Beaupin LK. Survivorship needs of adolescent and young adult cancer survivors: a concept mapping analysis. J Cancer Surviv. 2019;13(1):34–42.
Zonderman AB, Ejiogu N, Norbeck J, Evans MK. The influence of health disparities on targeting cancer prevention efforts. Am J Prev Med. 2014;46(3 Suppl 1):S87-97.
Shah SA, Adam MA, Thomas SM, et al. Racial disparities in differentiated thyroid cancer: have we bridged the gap? Thyroid. 2017;27(6):762–72.
Thomas SM, Reyes-Gastelum D, Milam J, et al. Worry about quality of life for younger versus older adult thyroid cancer survivors. J Clin Oncol. 2019;37(27_suppl):157.
Holge-Hazelton B, Timm HU, Graugaard C, et al. “Perhaps I will die young.” Fears and worries regarding disease and death among Danish adolescents and young adults with cancer. A mixed method study. Support Care Cancer. 2016;24(11):4727–37.
Bresner L, Banach R, Rodin G, et al. Cancer-related worry in Canadian thyroid cancer survivors. J Clin Endocrinol Metab. 2015;100(3):977–85.
Moye J, Wachen JS, Mulligan EA, et al. Assessing multidimensional worry in cancer survivors. Psychooncology. 2014;23(2):237–40.
Sodergren SC, Husson O, Robinson J, et al. Systematic review of the health-related quality of life issues facing adolescents and young adults with cancer. Qual Life Res. 2017;26(7):1659–72.
Hirai K, Shiozaki M, Motooka H, et al. Discrimination between worry and anxiety among cancer patients: development of a brief cancer-related worry inventory. Psychooncology. 2008;17(12):1172–9.
Yang Y, Li W, Wen Y, et al. Fear of cancer recurrence in adolescent and young adult cancer survivors: a systematic review of the literature. Psychooncology. 2019;28(4):675–86.
National Cancer Institute Staff. National Cancer Institute: study offers insights on health problems among AYA cancer survivors. 2020. https://www.cancer.gov/news-events/cancer-currents-blog/2020/aya-cancer-survivors-health-problems. Accessed March 2 2021.
Kwak M, Zebrack BJ, Meeske KA, et al. Trajectories of psychological distress in adolescent and young adult patients with cancer: a 1-year longitudinal study. J Clin Oncol. 2013;31(17):2160–6.
Esfandiari NH, Hughes DT, Reyes-Gastelum D, et al. Factors associated with diagnosis and treatment of thyroid microcarcinomas. J Clin Endocrinol Metab. 2019;104(12):6060–8.
Chen DW, Reyes-Gastelum D, Wallner LP, et al. Disparities in risk perception of thyroid cancer recurrence and death. Cancer. 2020;126(7):1512–21.
Papaleontiou M, Evron J, Esfandiari N, et al. Patient report of recurrent and persistent thyroid cancer. Thyroid. 2020;30(9):1297–305.
Evron JM, Reyes-Gastelum D, Banerjee M, et al. Role of patient maximizing-minimizing preferences in thyroid cancer surveillance. J Clin Oncol. 2019;37(32):3042–9.
Kovatch KJ, Reyes-Gastelum D, Hughes DT, et al. Assessment of voice outcomes following surgery for thyroid cancer. JAMA Otolaryngol Head Neck Surg. 2019;145:823–9.
Wallner LP, Reyes-Gastelum D, Hamilton AS, et al. Patient-perceived lack of choice in receipt of radioactive iodine for treatment of differentiated thyroid cancer. J Clin Oncol. 2019;37(24):2152–61.
Hughes DT, Reyes-Gastelum D, Kovatch KJ, et al. Energy level and fatigue after surgery for thyroid cancer: a population-based study of patient-reported outcomes. Surgery. 2020;167(1):102–9.
Katz SJ, Wallner LP, Abrahamse PH, et al. Treatment experiences of Latinas after diagnosis of breast cancer. Cancer. 2017;123(16):3022–30.
Chen DW, Reyes-Gastelum D, Veenstra CM, Hamilton AS, Banerjee M, Haymart MR. Financial hardship among hispanic women with thyroid cancer. Thyroid. 2021;31(5):752–9.
Dillman DA, Smyth JD, Christian LM. Internet, phone, mail, and mixed-mode surveys: the tailored design method. Hoboken: Wiley; 2014.
Chen DW, Reyes-Gastelum D, Hawley ST, Wallner LP, Hamilton AS, Haymart MR. Unmet information needs among hispanic women with thyroid cancer. J Clin Endocrinol Metab. 2021;106(7):e2680–7.
American Association for Public Opinion Research- Response rates. https://www.aapor.org/Education-Resources/For-Researchers/Poll-Survey-FAQ/Response-Rates-An-Overview.aspx. Accessed October 29 2020.
Janz NK, Hawley ST, Mujahid MS, et al. Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer. Cancer. 2011;117(9):1827–36.
Janz NK, Friese CR, Li Y, et al. Emotional well-being years post-treatment for breast cancer: prospective, multi-ethnic, and population-based analysis. J Cancer Surviv. 2014;8(1):131–42.
Janz NK, Li Y, Beesley LJ, et al. Worry about recurrence in a multi-ethnic population of breast cancer survivors and their partners. Support Care Cancer. 2016;24(11):4669–78.
NCCN distress thermometer and problem list for patients. 2020. https://www.nccn.org/patients/resources/life_with_cancer/pdf/nccn_distress_thermometer.pdf. Accessed December 1 2020.
Papaleontiou M, Zebrack B, Reyes-Gastelum D, Rosko AJ, Hawley ST, Hamilton AS, Ward KC, Haymart MR. Physician management of thyroid cancer patients' worry. J Cancer Surviv. 2021;15(3):418–26.
National Cancer Institute: Types of cancers in young people. https://www.cancer.gov/types/aya. Accessed March 2 2021.
Thewes B, Kaal SEJ, Custers JAE, et al. Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service. Support Care Cancer. 2018;26(5):1479–87.
Custers JA, Kwakkenbos L, van der Graaf WT, et al. Not as stable as we think: a descriptive study of 12 monthly assessments of fear of cancer recurrence among curatively-treated breast cancer survivors 0–5 years after surgery. Front Psychol. 2020;11:580979.
Sun H, Yang Y, Zhang J, et al. Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients. Neuropsychiatr Dis Treat. 2019;15:857–65.
Starreveld DEJ, Markovitz SE, van Breukelen G, Peters ML. The course of fear of cancer recurrence: different patterns by age in breast cancer survivors. Psychooncology. 2018;27(1):295–301.
Manne SL, Myers-Virtue S, Kissane D, et al. Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers. Psychooncology. 2017;26(11):1799–809.
Rogers SN, Mepani V, Jackson S, Lowe D. Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer. Br J Oral Maxillofac Surg. 2017;55(7):666–73.
Hedman C, Djarv T, Strang P, Lundgren CI. Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: a prospective Swedish population-based study. Thyroid. 2018;28:1609–17.
Roh JL, Kim JM, Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann Surg Oncol. 2011;18(5):1312–8.
Starmer H, Noureldine SI, Ozgursoy OB, Tufano RP. Voice outcomes following reoperative central neck dissection for recurrent/persistent thyroid cancer. Laryngoscope. 2015;125(11):2621–5.
Gapstur RL. Symptom burden: a concept analysis and implications for oncology nurses. Oncol Nurs Forum. 2007;34(3):673–80.
Gill A, Chakraborty A, Selby D. What is symptom burden: a qualitative exploration of patient definitions. J Palliat Care. 2012;28(2):83–9.
Cheng Huilin, Sit Janet W. H, So Winnie K. W. The symptom burden in breast cancer survivors. Psychooncol Supportive Care. 2016;8(1):40–6.
Cleeland CS. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. 2007;37:16–21.
Phillips KM, McGinty HL, Gonzalez BD, et al. Factors associated with breast cancer worry 3 years after completion of adjuvant treatment. Psychooncology. 2013;22(4):936–9.
Bubis LD, Davis L, Mahar A, et al. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J Clin Oncol. 2018;36(11):1103–11.
Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22.
Fardell JE, Thewes B, Turner J, et al. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv. 2016;10(4):663–73.
Acknowledgements
The authors thank Ms. Brittany Gay for her support in preparing this manuscript.
Funding
This work is supported by R01 CA201198 (National Cancer Institute) with additional R01 supplement from the Office of Research on Women’s Health (ORWH) to Dr. Haymart. Dr. Haymart is also supported by R01 HS024512 (Agency for Healthcare Research and Quality). N. Jackson Levin received research support from the National Cancer Institute institutional training grant T32-CA-236621. Dr. Debbie Chen receives research support from the National Institute of Diabetes and Digestive and Kidney Diseases institutional training grant T32-DK-007245. N Jackson Levin and A Zhang received this same Curtis Center support from the University of Michigan Vivian A. and James L. Curtis School of Social Work Center for Health Equity Research and Training, Signature Programs Initiatives. The collection of cancer incidence data in California was supported by the California Department of Public Health pursuant to California Health and Safety Code Sect. 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP006344; and the NCI’s SEER Program under contract HHSN261201800015I awarded to the University of Southern California. The collection of cancer incidence data in Georgia was supported by contract HHSN261201800003I, Task Order HHSN26100001 from NCI, and cooperative agreement 5NU58DP003875-04 from the CDC.
Author information
Authors and Affiliations
Contributions
Conceptualization: Nina Jackson Levin, Anao Zhang, David Reyes-Gastelum, Debbie W. Chen, Ann S. Hamilton, Bradley J. Zebrack, Megan R. Haymart.
Data curation: Hamilton, A.S.
Project administration: Hamilton, A.S.
Investigation: Chen, DW., Hamilton, A.S., Haymart M.R.
Formal analysis: Reyes-Gastelum, Zhang, A., Haymart M.R.
Writing—original draft: Jackson Levin, N., Haymart, M.R.
Writing—review and editing: Jackson Levin, N., Zhang, A., Reyes-Gastelum, D., Chen, D.W., Hamilton, A.S., Zebrack, B.J., Haymart, M.R.
Supervision: Haymart, M.R., Zhang, A., Zebrack, B.J.
Funding acquisition: Haymart, M.R.
Corresponding author
Ethics declarations
Ethics approval
The study was approved by the University of Michigan (HUM00113715), the University of Southern California (HS-16–00646), the Committee for the Protection of Human Subjects (California State Institutional Review Board), the Georgia Department of Public Health, and the Emory University Institutional Review Boards (IRB00093983) and received approval from the California Cancer Registry. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
A waiver of written informed consent was obtained for all subjects in this study.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Cancer Institute. The ideas and opinions expressed herein are those of the authors and endorsement by the State of California and State of Georgia Departments of Public Health, the NCI and CDC, or their contractors and subcontractors is not intended nor should be inferred.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jackson Levin, N., Zhang, A., Reyes-Gastelum, D. et al. Change in worry over time among Hispanic women with thyroid cancer. J Cancer Surviv 16, 844–852 (2022). https://doi.org/10.1007/s11764-021-01078-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-021-01078-8